Litcius/Paper detail

Randomized trial of argatroban plus recombinant tissue-type plasminogen activator for acute ischemic stroke (ARAIS): Rationale and design

Yingying Yang, Zhonghe Zhou, Yuesong Pan, Dawei Chen, Yilong Wang

2020American Heart Journal14 citationsDOI

Topics & Concepts

MedicineArgatrobanPlasminogen activatorRandomized controlled trialRecombinant DNAStroke (engine)Tissue plasminogen activatorRecombinant tissue plasminogen activatorIschemic strokeInternal medicinePharmacologyIschemiaGenePlateletMechanical engineeringEngineeringThrombinModified Rankin ScaleChemistryBiochemistryAcute Ischemic Stroke ManagementS100 Proteins and AnnexinsIntracerebral and Subarachnoid Hemorrhage Research
Randomized trial of argatroban plus recombinant tissue-type plasminogen activator for acute ischemic stroke (ARAIS): Rationale and design | Litcius